APA
Foy J., Bertolus C., Michallet M., Deneuve S., Incitti R., Bendriss-Vermare N., Albaret M., Ortiz-Cuaran S., Thomas E., Colombe A., Py C., Gadot N., Michot J., Fayette J., Viari A., Van den Eynde B., Goudot P., Devouassoux-Shisheboran M., Puisieux A., Caux C., Zrounba P., Lantuejoul S. & Saintigny P. (20180507). The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade. : Annals of oncology : official journal of the European Society for Medical Oncology.
Chicago
Foy J-P, Bertolus C, Michallet M-C, Deneuve S, Incitti R, Bendriss-Vermare N, Albaret M-A, Ortiz-Cuaran S, Thomas E, Colombe A, Py C, Gadot N, Michot J-P, Fayette J, Viari A, Van den Eynde B, Goudot P, Devouassoux-Shisheboran M, Puisieux A, Caux C, Zrounba P, Lantuejoul S and Saintigny P. 20180507. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade. : Annals of oncology : official journal of the European Society for Medical Oncology.
Harvard
Foy J., Bertolus C., Michallet M., Deneuve S., Incitti R., Bendriss-Vermare N., Albaret M., Ortiz-Cuaran S., Thomas E., Colombe A., Py C., Gadot N., Michot J., Fayette J., Viari A., Van den Eynde B., Goudot P., Devouassoux-Shisheboran M., Puisieux A., Caux C., Zrounba P., Lantuejoul S. and Saintigny P. (20180507). The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade. : Annals of oncology : official journal of the European Society for Medical Oncology.
MLA
Foy J-P, Bertolus C, Michallet M-C, Deneuve S, Incitti R, Bendriss-Vermare N, Albaret M-A, Ortiz-Cuaran S, Thomas E, Colombe A, Py C, Gadot N, Michot J-P, Fayette J, Viari A, Van den Eynde B, Goudot P, Devouassoux-Shisheboran M, Puisieux A, Caux C, Zrounba P, Lantuejoul S and Saintigny P. The immune microenvironment of HPV-negative oral squamous cell carcinoma from never-smokers and never-drinkers patients suggests higher clinical benefit of IDO1 and PD1/PD-L1 blockade. : Annals of oncology : official journal of the European Society for Medical Oncology. 20180507.